Regrow Therapy is an advanced, scientifically developed regenerative treatment designed to preserve the hip joint and prevent the progression of Avascular Necrosis (AVN) of the hip. By restoring damaged bone tissue and improving blood supply, this therapy offers patients the possibility of avoiding or delaying hip replacement surgery — especially in the early and mid-stages of AVN.
In Avascular Necrosis, the blood supply to the femoral head decreases, leading to bone death, collapse, and severe hip pain. Regrow Therapy works by harvesting the patient’s own stem cells or bone marrow-derived cells, processing them in a controlled laboratory environment, and reintroducing them into the affected hip. These cells stimulate natural bone regeneration, enhance healing, and help restore the structural integrity of the femoral head.
This therapy is performed using minimally invasive techniques such as core decompression, where channels are created in the bone to relieve pressure and improve blood flow. The regenerative cells are then injected into these channels, promoting new bone formation and preventing further joint damage.
Regrow Therapy is ideal for patients in the early stages of AVN who experience persistent hip pain, stiffness, or difficulty walking but still have preserved joint shape and cartilage. With timely intervention, this therapy can significantly slow disease progression, reduce symptoms, and help maintain natural joint movement for years.
At our center, Regrow Therapy is offered as part of a comprehensive hip preservation program focused on early diagnosis, precision imaging, targeted regenerative treatment, and structured rehabilitation — ensuring the best possible outcomes for patients seeking alternatives to major surgery.